This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 Biotech Stocks Rising on Big Volume

Questcor Pharmaceuticals

Questcor Pharmaceuticals (QCOR), a biopharmaceutical company, provides prescription drugs for the treatment of multiple sclerosis, nephrotic syndrome and infantile spasms indications. Its products include H.P. Acthar Gel and Doral. This stock is trading up 3.7% at $33.90 in recent trading.

Today's Volume: 4.18 million

Average Volume: 1.62 million

Volume % Change: 323%

Shares of QCOR are ripping higher today after the company said its net income nearly doubled in the fourth quarter on an increase in prescriptions of its H.P. Acthar Gel, which is used to treat several autoimmune and inflammatory diseases.

>>5 Stocks Set to Soar on Bullish Earnings

From a technical perspective, QCOR is trending up here and moving back above its 200-day moving average of $33.87 with heavy upside volume. This stock has been uptrending strong since it cleared its 50-day at $27.54 a few weeks ago, with shares soaring to its intraday high of $34.74. During that uptrend, shares of QCOR have been consistently making higher lows and higher highs, which is bullish technical price action.

Traders should now look for long-biased trades in QCOR as long as it's trending above today's low of $31.50 or above its 200-day at $33.87 with strong upside volume flows. I would consider any upside volume day that registers near or above its three-month average action of 1.62 million shares as bullish. If QCOR can maintain that trend, then this stock will set up to trend well north of $40 a share. In fact, the next major resistance level for QCOR sits at $50.

Jazz Pharmaceuticals

Jazz Pharmaceuticals (JAZZ - Get Report) is a specialty pharmaceutical company focused on developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. This stock is trading up 3.1% at $58.62 in recent trading.

Today's Volume: 886,000

Average Volume: 472,361

Volume % Change: 203%

Shares of JAZZ are moving higher today after the company reported that fourth-quarter revenue surged due to acquisitions and sales growth for its narcolepsy treatment Xyrem.

From a technical perspective, JAZZ is spiking higher here right off its 50-day moving average of $55.76 with above-average volume. This move has started to push shares of JAZZ into breakout territory, since the stock has flirted with some near-term overhead resistance levels at $57.70 to $59.19. At last check, JAZZ has hit an intraday high of $59.89 and volume is well above its three-month average action of 472,361 shares.
2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
OPTR $0.00 0.00%
JAZZ $152.51 1.20%
QCOR $93.60 1.65%
AAPL $93.66 -0.09%
FB $118.58 0.85%


Chart of I:DJI
DOW 17,891.16 +117.52 0.66%
S&P 500 2,081.43 +16.13 0.78%
NASDAQ 4,817.5940 +42.2360 0.88%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs